Wednesday, November 2, 2011

What Every Hypothyroid Patient Should Know about Synthroid


Synthroid, a brand of thyroid hormone, is the third most prescribed drug in the United States.  Back in the 1980's, Synthroid was the only brand of thyroid hormone that mainstream physicians would prescribe. Most physicians refused to prescribe other brands of thyroid medication. This was due in part by the powerful marketing campaign by Synthroid's manufacturers - formerly Knoll Manforce Pharmaceuticals (Knoll) and now Abbott Laboratories (Abbott). In addition, Synthroid received the "stamp of approval" from the endocrinology specialty. Mainstream medical physicians believed and many still do that Synthroid was the absolute best of the thyroid hormone products.
Unfortunately, a growing number of physicians were becoming frustrated with the lack of consistent results with Synthroid. While some patients did improve, many others did not, causing physicians to question the reliability of this heavily marketed drug.
With the emergence of progressive thinking medical physicians came a new way of looking at disease as well as a more productive way of prescribing medication.
More and more physicians realized the limitation of Synthroid and began prescribing Armour Thyroid or Thyrolar. The results were astonishing!! Physicians were seeing a greater percentage of their patients improving.
From a pharmaceutical stand-point, Synthroid is a T4 only medication while Armour Thyroid and Thyrolar are both T3 and T4. These are brands of thyroid hormone that contain both T4 (levothyroxine) and T3 (triiodothyronine).
Despite Synthroid's relative ineffectiveness, when mainstream MDs in the United States diagnose hypothyroidism, they habitually write "Synthroid" on their prescription pads. Why? Because dogged endorsements of the drug by endocrinologists have fused the words hypothyroidism and Synthroid as inseparably as runny nose and Kleenex.
Why Endocrinologists Endorse Synthroid
Endocrinologists dictate other mainstream medical specialists' beliefs about hypothyroidism and its treatment. One such belief is that the proper aim of thyroid hormone therapy is to bring the patient's thyroid-stimulating hormone (TSH) blood level into the reference range (formerly called the "normal range"). To endocrinologists, when a patient's TSH level is within this range, the patient is said to be well, even if he or she remains disabled by hypothyroid symptoms.
Treating hypothyroid patients according to this criterion has left millions of them chronically ill, disabled, and prematurely dead. The reason is clear. During primary hypothyroidism, the pituitary gland increases its release of TSH, raising the blood level above the reference range. The pituitary is highly sensitive to T4, and small dosages of T4 decrease the pituitary release of TSH, lowering it into the reference range. Tissues other than the pituitary are comparatively insensitive to small dosages of T4. Much higher dosages are required to normalize the metabolism of these other tissues. However, T4 does not increase the metabolism of many patients' tissues, no matter how high the dosage. Only a thyroid hormone preparation that contains T3 will accelerate these patients' metabolism. Hence, when T4 therapy normalizes TSH blood levels of many patients, it leaves their metabolism subnormal. These patients remain symptomatic despite their normal TSH levels. This finding has led researchers to urge physicians to no longer base patients' thyroid hormone dosages by TSH levels.
In view of this, why do endocrinologists resolutely endorse Synthroid as the only brand of thyroid hormone any hypothyroid patient ever needs to use? The cause is a complex interplay of factors. Prominent among them are financial incentives to the endocrinology specialty from corporate marketers of Synthroid. The corporations have richly funded the specialty. He who pays the piper, of course, calls the tune. This reality makes the proposition plausible that lavish funding by these corporations has shaped endocrinologists' beliefs about hypothyroidism - beliefs that are favorable, quid pro quo, to the financial interests of the corporations, yet shown false by substantial scientific evidence.
Ample evidence supports the belief that endocrinologists' endorsement of Synthroid has been strongly influenced by financial incentives from the corporations. An example is a million-dollar donation by Knoll to the American Thyroid Society (ATS) to fund thyroid research. The studies ATS funds with that money will be those whose outcomes are likely to favor the financial interests of the corporation. Studies that would militate against the corporation's financial interests are not likely to be funded. This type of mutual support ensures a continuing financial relationship between research organizations and funding corporations.
Renowned thyroid patient advocate Mary Shomon recently noted that the American Association of Clinical Endocrinologists (AACE) "has a longstanding financial relationship with the manufacturers of Synthroid." The AACE's web page listing its sponsors verifies that Synthroid subsidizes the organization. Knoll funded AACE's work to develop practice guidelines for the diagnosis and treatment of hypothyroidism. It is no surprise that the guidelines mention no treatment for hypothyroidism other than T4. This endorsement of T4 dovetails with endocrinologists' oft-repeated public endorsement of Synthroid.
Dr. Rhoda Cobin, president of AACE, recently wrote in the Wall Street Journal that the organization does not endorse specific products. Yet in the same letter, she - the AACE's top official - endorsed Synthroid: "The 3,700 physicians in our organization, all specialists in thyroid disease, have found that Synthroid has a long record of safety, efficacy, reliability and consistency." Mary Shomon pointed out that the homepage of the Synthroid website prominently displays an AACE press release supportive of Synthroid.
FDA Action against Synthroid
Despite such assurances by endocrinologists, and despite corporations having marketed Synthroid for 30 years, the FDA has not approved the product for the treatment of hypothyroidism. Knoll recently requested that the FDA waive requirements for "adequate and well-controlled studies" of Synthroid and grant it status as "generally recognized as safe and effective." The FDA refused and required Knoll to apply for a new drug application following proper testing for safety and effectiveness.
The reasons FDA gave for its decision about Synthroid contradict the reassurances of endocrinologists.' "Patients using Synthroid," the FDA wrote, "have experienced significant, unintended variations in their doses of [T4] ... these variations are not conducive to proper control of hypothyroidism."
The FDA also wrote of Synthroid: "Its formula has been changed numerous times throughout its marketing history."
The agency cited a long history of manufacturing problems, subpotency, stability, and reliability issues. "In August of 1989," the FDA noted, "Knoll initiated a recall of 21 lots of Synthroid tablets." The reason for the recall was low potency during stability studies. In 1991, Knoll recalled 26 subpotent lots of Synthroid in February and other lots in June. Inspections of a Synthroid manufacturing plant led to citations for deviations from good manufacturing practices: two in April 1991, and nine in December 1992. Knoll distributed subpotent Synthroid during 1990, 1991, and 1992. The FDA summarized:

"The history of potency failures ... indicates that Synthroid has not been reliably potent and stable. Furthermore, Knoll's use of an overage [in potency] that has not remained consistent over the years suggests that Synthroid has stability, potency, and consistency problems. Although you [Knoll] claim that Synthroid has been carefully manufactured, the violations of current good manufacturing practices discussed above indicate that Knoll has not always manufactured Synthroid in accordance with current standards for pharmaceutical manufacturing."
On August 1, 2001, Abbott Labs, after acquiring Knoll, submitted to the FDA a new drug application for Synthroid. Those concerned over the Synthroid problem can stay abreast of FDA actions against its manufacturer through Mary Shomon's newsletter, Sticking Out Our Necks.
In summary, evidence indicates that financial incentives from the marketers of Synthroid have influenced endocrinologists to endorse the product. Synthroid has a history of manufacturing, stability, and potency problems, and it has not met FDA criteria for effectiveness and safety. These problems with product quality led to FDA action against Synthroid. Many alternative medical physicians report that treatment results with Synthroid are inferior to those with products containing both T4 and T3, or T3 alone. 

About Synthroid

Synthroid is used as a replacement for those whose thyroid glands do not produce enough of the thyroid hormone. Synthroid can also be used to improve the symptoms of a thyroid deficiency such as lack of energy, slow speech, weigh gain, hair loss, an unusual sensitivity to the cold, and dry thick Stamina skin. Synthroid has also helped to treat an enlarged thyroid gland which is sometimes called a goiter.



Your Prescribing Doctor Must Know

Tell your physician if you have experienced any of these conditions for Synthroid:
  • Diabetes mellitus
  • Low levels of pituitary hormone
  • Heart disease
  • Angina
  • Previous heart attack
  • An unusual or abnormal reaction to levothyroxine, other thyroid hormones, medications, foods, dyes or preservatives
  • High blood pressure
  • Dieting or on a weight loss program
If you are pregnant, breast feeding or currently trying to become pregnant, make sure your doctor is aware of your maternal condition; as Synthroid may not be recommended for certain situations.

Administering Synthroid

It is important that you leave regular intervals between every dose of medication. Doing so will help the efficiency of this drug. Every prescription comes with instructions on the reverse side of each bottle or packaging. It is important that you follow the written instructions carefully as not all of them are identical.
Synthroid tablets should be taken orally on an empty stomach 30 to 60 minutes before a meal with a glass of water. Remember, when taking Synthroid or any prescription drug to always follow the label closely. Be sure to place doses evenly and do not take more than directed.
Synthroid should only be taken as instructed by a professional physician. Be sure to remember not to stop taking this medicine without consulting your physician first about how to stop safely. If you are researching this medication for your child, keep in mind that children often have special dosage instructions. Ask your physician about these differences prior to starting this medication if this is the case.

What if I Miss a Dose of Synthroid

In the event that a dose of Synthroid was missed, take one as soon as you can. But if your next scheduled dose is near, wait until that next dose is due and just skip the one you’ve already missed.
Caution: You should NEVER take double or extra doses of Synthroid. Always ask your physician further about missed doses, as he may have special instructions.

Conflicting Medications

Always consult the doctor who prescribed Synthroid to you; as this is only a partial interacting medicines list:
  • Warfarin
  • Rifampin
  • Amiodarone
  • Sucralfate
  • Rifabutin
  • Digoxin
  • Colestipol
  • Soy isoflavones
  • Antacids
  • Ketamine
  • Phenytoin
  • Theophylline
  • Carbamazepine
  • Calcium supplements such as Tums
  • Female hormones including contraceptive or birth control pills
  • Cholestyramine
  • Medications for colds and breathing difficulties
  • Prednisone or other corticosteroids
  • Medications for mental depression
  • Medications or herbals used to decrease weight or appetite
  • Phenobarbital or other barbiturate medications
It is important that your physician knows if you are currently taking any medications along with Synthroid; as there may be conflicting interaction. Let your physician know if you:
  • Are a smoker
  • Use any other legal or illegal drugs or substances
  • Consume alcohol or caffeine on a regular basis
All of the activities listed above could affect the results you see from taking Synthroid.

Synthroid Common side effects

The following are side effects known to be common of Synthroid and they are experienced by users. These are common, side effects but if you feel uneasy or they persist do not hesitate to contact your physician.
  • Hair loss
  • Changes in menstrual periods
  • Fever
  • Irritability
  • Changes in appetite
  • Headache
  • Diarrhea
  • Leg cramps
  • Nausea or vomiting
  • Weight loss
  • Tremors
  • Trouble sleeping
None of the above listed side effects require immediate medical attention. If you continue to experience these Common side effects for a few days, consult your prescribing physician for more advice. It is very important that you do not try to treat these symptoms on your own. Note: that elderly patients have a higher likelihood of experiencing side effects.

Synthroid Least Common side effects

The following side effects are rare and should not be taken lightly. If you experience any of these less common side effects from taking Synthroid consult your healthcare professional immediately. The following are less common side effects associated withSynthroid:
  • Chest pain
  • Nervousness
  • Fast or irregular heartbeat or pulse rate
  • Excessive sweating or intolerance to heat
  • Skin rash or hives
  • Difficulty breathing, wheezing or shortness of breath
  • Swelling of ankles, feet or legs
It is important that you contact your physician right away if you've experienced any of the Less Common side effects listed above.

Synthroid Precautions

You should receive physical checkups on a regular basis; especially while taking prescription medicines. This is an easy way to monitor your progress and ensure your physical health as well. Your body may build up a dependency on Synthroid and you may experience dizziness or drowsiness up to a few days after you stop taking this medication.
Patients are advised not to operate heavy machinery or automobiles until the full effect of Synthroid is known. Do not consume alcohol while taking Synthroid. Make sure your doctor is aware of upcoming surgeries you may have scheduled; or will be scheduling while taking this medication.
Contact your doctor for professional advice if you experience a cold, coughs or allergies. You should not try to treat yourself for such symptoms. Some ingredients found in other medications may have conflicting affects while taking Synthroid and may affect desired results. Synthroid cannot be given to any person without a prescription. Sharing Synthroid is against the law.

How To Store Synthroid

The following is general storage information for Synthroid:
  • It is important that you store Synthroid at temperatures between 59 and 86 degrees Fahrenheit.
  • Make sure Synthroid is kept away from direct sunlight and moisture.
  • Be sure to store Synthroid out of reach of any pets or small children; in a small childproof container.
  • Dispose of any expired or unused Synthroid properly.